George Health innovations recognised for potential to transform global health
A new Australian product designed to make kidney dialysis more broadly available at low cost has won...
23 November, 2020
Better treatments, Better care,
New frontiers
George
Clinical
Science, service, solutions. A leading contract research organisation in Asia-Pacific with global capabilities.
Novel Treatments
George
Medicines
Innovative, affordable treatments for the leading causes of death globally.
Disruptive technologies
George Health Technologies
Affordable, personalised digital health care for all.
A leader in global health
The George Institute for Global Health
All the George Health businesses benefit from exclusive access to the research, intellectual property, and scientific expertise of The George Institute for Global Health – a world-leading, global medical research institute focused on the biggest killers: non-communicable diseases and injury.
Non-communicable diseases – a unique 21st century global health challenge
5 billion
5 billion people have no reliable access to essential health care.
100 million
100 million people will die from chronic diseases before they reach 60.
Heart attack and stroke are the world’s leading cause of death.
US$47 trillion
The United Nations has projected cumulative losses to the global economy due to chronic disease could reach US$47 trillion by 2030.
Latest News
Transforming the treatment for kidney failure
Affordable dialysis worldwide: Q+A with John Knight of Ellen Medical Devices about the world’s fir...
22 October, 2020
Multi-million-dollar mission to tackle major global health challenges
$53 million cash injection from Australian investors – one of the country’s largest-ever pri...
10 March, 2020